Pear Therapeutics to Become a Public Company
Pear Therapeutics, Inc. (“Pear”), the leader in developing and commercializing prescription digital therapeutics (PDTs) to…
Arboretum Venture’s Nicole J. Walker Joins Venture Forward Board of Directors
Venture Forward is excited to celebrate its one-year anniversary as well as the appointment of…
Arboretum_JDJune 18, 2021
Navv Systems Completes Seed Financing to Accelerate Commercialization
Navv Systems, a Southeastern Michigan-based healthcare technology company focused on hospital personnel location and equipment…
Arboretum_JDJune 9, 2021
Francis Medical Announces Positive Data from VAPOR 1 IDE Study
Francis Medical, Inc., a privately-held medical device company developing an innovative and proprietary water vapor…
Arboretum_JDJune 8, 2021
EQRx Reports Positive Phase 3 Result for Sugemalimab (PD-L1 program)
EQRx, a company committed to developing and delivering important new medicines at lower prices, along…
Arboretum_JDMay 28, 2021
Koya Medical Receives FDA Clearance for Compression Therapy System
Dayspring compression therapy system is now FDA cleared for treatment of lymphedema and venous diseases…
Arboretum_JDMay 26, 2021
EQRx Announces Results of Aumolertinib’s Phase III Trial
Aumolertinib Significantly Prolongs Progression-Free Survival with Fewer Side Effects in the First-Line Treatment of Patients…
Arboretum_JDMay 20, 2021
Strata Oncology Launches Strata Assistant Epic app to Integrate Precision Oncology into Clinical Practice
Strata Oncology, Inc., a precision oncology company advancing molecular indications for cancer therapies, today announced…
Arboretum_JDMay 19, 2021
ArborMetrix Announces Maria Siambekos as New CEO
ArborMetrix today announced its Board of Directors has appointed Maria Siambekos, M.B.A., as Chief Executive…
Arboretum_JDMay 11, 2021